ICP
PACB icon

Interchange Capital Partners’s Pacific Biosciences PACB Stock Holding History

Interchange Capital Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,400
Closed -$25.3K – 462
2026
Q1 		$25.3K Buy
21,400
+4,587
+27% +$8.21K 0.01% 280
2025
Q4 		$31.4K Sell
16,813
-982
-6% -$1.89K 0.01% 423
2025
Q3 		$22.8K Sell
17,795
-512
-3% -$693 ﹤0.01% 365
2025
Q2 		$22.7K Sell
18,307
-5,256
-22% -$6.07K 0.01% 280
2025
Q1 		$27.8K Sell
23,563
-6,433
-21% -$9.87K 0.01% 270
2024
Q4 		$52.9K Buy
29,996
+1,034
+4% +$2.02K 0.02% 252
2024
Q3 		$49.2K Sell
28,962
-2,237
-7% -$3.67K 0.02% 269
2024
Q2 		$42.7K Buy
31,199
+2,558
+9% +$5.17K 0.02% 271
2024
Q1 		$114K Buy
28,641
+9,932
+53% +$58.2K 0.08% 167
2023
Q4 		$184K Buy
18,709
+1,991
+12% +$16.3K 0.14% 148
2023
Q3 		$140K Buy
16,718
+4,058
+32% +$46.4K 0.11% 147
2023
Q2 		$168K Buy
+12,660
New +$154K 0.13% 147
2022
Q3 		– Sell
-10,506
Closed -$46K – 167
2022
Q2 		$46K Sell
10,506
-713
-6% -$4.33K 0.05% 153
2022
Q1 		$102K Buy
+11,219
New +$129K 0.1% 155

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Interchange Capital Partners's PACB Position: Q2 2026 in Review

Interchange Capital Partners sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 21,400 shares — an estimated $25.3K sold.

Interchange Capital Partners first reported a position in PACB in Q1 2022 and held it in 14 quarters. The position peaked at $184K in Q4 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Interchange Capital Partners reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • Interchange Capital Partners sold 21,400 Pacific Biosciences shares in Q2 2026, an estimated $25.3K.
  • Interchange Capital Partners first reported a position in Pacific Biosciences in Q1 2022 and held it in 14 quarters.
  • Interchange Capital Partners's Pacific Biosciences position peaked at $184K in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.